University of California San Francisco
Give to UCSFA new study by UCSF researchers identified a surprising way that the brain’s immune cells help to form new memories.
The COVID-19 pandemic is a critical time to think about how best to manage the care of older adults, both for their sake and for the near- and longer-term costs and stresses to the health care system, according to a new commentary by a UCSF clinician.
Based on findings from a new study, future research should examine how to incorporate functional, cognitive and psychological factors in the pre-surgery assessment of older adults.
Understanding the biological differences that drive distinct symptoms of Alzheimer’s disease could lead to more personalized patient care and potentially therapies targeted to patients’ individual needs.
Scientists at UCSF are exploring how we can improve our bodies – now and in the future – with science that sounds like sci-fi.
English and Italian speakers with dementia-related language impairment experience distinct kinds of speech and reading difficulties based on features of their native languages.
A physically and mentally active lifestyle confers resilience to frontotemporal dementia, even in people whose genetic profile makes the eventual development of the disease virtually inevitable.
Advances in medicine and public health have dramatically extended the lifespan of hearts, lungs, and other vital organs. But for women, the ovaries remain a stubborn exception. That may soon change, says fertility expert Marcelle Cedars.
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.
No one can see the future, but that won’t stop us from trying. We asked UCSF faculty and alumni to score these predictions for likelihood and impact.
Adam L. Boxer answers questions about the potential of "basket trials" to accelerate drug development for dementia and neurodegenerative disease.
The net clinical benefit of anticoagulants for atrial fibrillation decreases with age.
The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and UC San Francisco, to advance treatments for frontotemporal lobar degeneration.
Scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia, adding to growing evidence that the loss of brain cells associated with dementia spreads via the synaptic connections between established brain networks.
A monthly, 40-minute phone call from a non-clinical professional may suppress or reverse the trajectory of depression so frequently experienced by family members caring for patients with dementia at home.